EUVIMEDEUVIMED entdecken
Crossref

Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score‐weighted analyses of a nationwide claim‐based database

Mitsuru Wada, Yuko Y Inoue, Michikazu Nakai, Yoko Sumita, Reina Tonegawa-Kuji, Yuichiro Miyazaki, Akinori Wakamiya, Keiko Shimamoto, Nobuhiko Ueda, Kenzaburo Nakajima, Tsukasa Kamakura iD, Kenichiro Yamagata und 7 weitere

Pacing and Clinical Electrophysiology · 2023-08 · 46 (8) · 833-839

DOI: 10.1111/pace.14789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 23.07.2023. Verfasst von Mitsuru Wada und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Pacemaker, Artificial, Heart Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: EP Cruise, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Infection is one of the most important complications associated with cardiac implantable electronic device (CIED) therapy. The number of reports comparing the outcomes of transvenous lead extraction (TLE), surgical lead extraction, and conservative treatment for CIED infections using a real‐world database is limited. This study investigated the association between the treatment strategies for CIED infections and their outcomes.

Methods

We performed a retrospective analysis of 3605 patients with CIED infections admitted to 681 hospitals using a nationwide claim‐based database collected between April 2012 and March 2018.

Results

We divided the 3605 patients into TLE ( n = 938 [26%]), surgical lead extraction ( n = 182 [5.0%]), and conservative treatment ( n = 2485 [69%]) groups. TLE was performed more frequently in younger patients and at larger hospitals ( p for trend < .001 for both). The rate of TLE increased during the study period, whereas that of surgical lead extraction decreased ( p for trend < .001 for both). TLE was associated with lower in‐hospital mortality (vs. surgical lead extraction: odds ratio [OR], 0.20; 95% CI, 0.06–0.70; vs. conservative treatment: OR, 0.45; 95% CI: 0.22–0.94) and lower 30‐day readmission rates (vs. surgical lead extraction: OR, 0.18; 95% CI: 0.06–0.56; vs. conservative treatment: OR, 0.06; 95% CI, 0.03–0.13) in propensity score‐weighted analyses.

Conclusions

Only 26% of patients hospitalized for CIED infections received TLE. TLE was associated with significantly lower in‐hospital mortality and 30‐day recurrence rates than surgical lead extraction and conservative treatment, suggesting that TLE should be more widely recommended as a first‐line treatment for CIED infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantablePacemaker, ArtificialHeart DiseasesHumansConservative TreatmentRetrospective StudiesPropensity ScoreDevice RemovalTreatment Outcome

Stichwörter der Autor:innen

cardiovascular infectiondevice removalexcimer laserimplantable cardioverter defibrillatorpacemaker

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Open Innovation Center, National Cerebral and Cardiovascular Center, Suita, Japan.

ORCID-Profile: Tsukasa Kamakura, Satoshi Nagase, Kengo Kusano

Förderung

  • EP Cruise, Inc.

Zitieren

APA

Wada, M., Inoue, Y. Y., Nakai, M., Sumita, Y., Tonegawa-Kuji, R., Miyazaki, Y., Wakamiya, A., Shimamoto, K., Ueda, N., Nakajima, K., Kamakura, T., Yamagata, K., Ishibashi, K., Miyamoto, K., Nagase, S., Aiba, T., Iwanaga, Y., Miyamoto, Y., & Kusano, K. (2023). Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score‐weighted analyses of a nationwide claim‐based database. Pacing and Clinical Electrophysiology, 46(8), 833-839. https://doi.org/10.1111/pace.14789

Vancouver

Wada M, Inoue YY, Nakai M, Sumita Y, Tonegawa-Kuji R, Miyazaki Y, et al. Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score‐weighted analyses of a nationwide claim‐based database. Pacing and Clinical Electrophysiology. 2023;46(8):833-839. doi:10.1111/pace.14789

BibTeX
@article{Wada2023,
  author = {Wada, Mitsuru and Inoue, Yuko Y and Nakai, Michikazu and Sumita, Yoko and Tonegawa-Kuji, Reina and Miyazaki, Yuichiro and Wakamiya, Akinori and Shimamoto, Keiko and Ueda, Nobuhiko and Nakajima, Kenzaburo and Kamakura, Tsukasa and Yamagata, Kenichiro and Ishibashi, Kohei and Miyamoto, Koji and Nagase, Satoshi and Aiba, Takeshi and Iwanaga, Yoshitaka and Miyamoto, Yoshihiro and Kusano, Kengo},
  title = {Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score‐weighted analyses of a nationwide claim‐based database},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2023},
  volume = {46},
  number = {8},
  pages = {833--839},
  doi = {10.1111/pace.14789}
}
Kostenlos starten →